This
paper briefly examines Bristol-Myers Squibb's (BMS) entry into the
market and
discusses what new innocations this company has to offer the pharmaceutical
industry. The paper then addressses the issue of market
competition and discusses the different competitive players in the industry. It then explains product substitutes that BMS produces and concludes by mentioning its suppliers and buyers.